I agree that this site is using cookies. You can find further informations here.
X
Wagenius, G.
57  results:
Search for persons X
?
1

P1.25-05 Real-World Outcomes in Non-metastatic Non-small Ce..:

Daumont, M.J. ; Rault, C. ; Baltus, H....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S269-S270 , 2023
Link: https://doi.org/10.1016/..
 
?
2

51P Real-word outcomes of immunotherapy in non-small cell l..:

Wagenius, G. ; Vikström, A. ; Berglund, A....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S71-S72 , 2023
Link: https://doi.org/10.1016/..
 
?
3

MA14.03 Targetable Driver Alterations in Non-adenocarcinoma..:

Isaksson, J. ; Berglund, A. ; Willén, L....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S149 , 2023
Link: https://doi.org/10.1016/..
 
?
4

EP08.01-083 Real-World PD-(L)1 Inhibitor Treatment Pattern ..:

Wagenius, G. ; Vikström, A. ; Berglund, A....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S380-S381 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Low level of education is associated with later stage at di..:

Eriksson, H. ; Lyth, J. ; Månsson-Brahme, E....
European Journal of Cancer.  49 (2013)  12 - p. 2705-2716 , 2013
Link: https://doi.org/10.1016/..
 
?
6

Prognostic subclassifications of T1 cutaneous melanomas bas..:

Lyth, J. ; Hansson, J. ; Ingvar, C....
British Journal of Dermatology.  168 (2013)  4 - p. 779-786 , 2013
Link: https://doi.org/10.1111/..
 
?
7

Concurrent cetuximab and radiotherapy after docetaxel–cispl..:

Hallqvist, A. ; Wagenius, G. ; Rylander, H....
Lung Cancer.  71 (2011)  2 - p. 166-172 , 2011
Link: https://doi.org/10.1016/..
 
?
8

How to improve loco-regional control in stages IIIa–b NSCLC:

Nyman, J. ; Friesland, S. ; Hallqvist, A....
Lung Cancer.  65 (2009)  1 - p. 62-67 , 2009
Link: https://doi.org/10.1016/..
 
?
9

313 Prevention therapy of fatigue:

Honore, P. Hartvig ; Wagenius, G. ; Aulin, J.
European Journal of Cancer Supplements.  7 (2009)  2 - p. 76 , 2009
Link: https://doi.org/10.1016/..
 
?
10

Phase II studies on docetaxel alone every third week, or we..:

Albertsson, M. ; Johansson, B. ; Friesland, S....
Medical Oncology.  24 (2007)  4 - p. 407-412 , 2007
Link: https://doi.org/10.1007/..
 
?
11

PCN27 COST-EFFECTIVENESS OF HUMAN INTERFERON-ALPHAAS ADJUVA..:

Kasteng, F ; Stadler, R ; Wagenius, G.
Value in Health.  10 (2007)  6 - p. A330 , 2007
Link: https://doi.org/10.1016/..
 
?
12

Genes associated with telomerase activity levels in esophag..:

Bergqvist, M. ; Brattström, D. ; Brodin, D....
Diseases of the Esophagus.  19 (2006)  1 - p. 20-23 , 2006
Link: https://doi.org/10.1111/..
 
?
13

HER-2 overexpression (3+) in patients with squamous cell es..:

Dreilich, M. ; Wanders, A. ; Brattström, D....
Diseases of the Esophagus.  19 (2006)  4 - p. 224-231 , 2006
Link: https://doi.org/10.1111/..
 
?
14

P-065 The role of a cytokeratin assay measuring cytokeratin..:

Klinga, A. ; Bergqvist, M. ; Brattström, D....
Lung Cancer.  49 (2005)  - p. S131 , 2005
Link: https://doi.org/10.1016/..
 
?
15

P-604 Radiotherapy with daily Taxol in locally advanced NSC..:

Brodin, O. ; Helsing, M. ; Henriksson, R..
Lung Cancer.  49 (2005)  - p. S277 , 2005
Link: https://doi.org/10.1016/..
 
1-15